The Delhi High Court has asked Serum Institute of India and Bharat Biotech to disclose the capacity they have to manufacture Covaxin and Covishield vaccines, respectively. A bench of the Delhi High Court comprising Justice Vipin Sanghi and Rekha Palli directed the Centre to explain in its affidavit the reasons behind keeping the vaccination drive strictly under the government’s control. The court directed the oganisations to file the affidavit to clarify the capacities to produce Covisiled and Covaxin per day/week/month. The court said, “We are either donating or selling off the vaccines to other countries without looking at our own needs. There has to be a sense of urgency about this.”